Axcella Health
$5.999876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.26 (+4.54%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Axcella Health and other stocks, options, and ETFs commission-free!
About AXLA
Axcella Health Inc. Common Stock, also called Axcella Health, is a biotechnology company, which engages in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options. Its product pipeline includes AXA1665, AXA1125, AXA1957, AXA2678, and AXA4010. The company was founded by Noubar B. Afeyan, Geoffrey von Maltzahn, and David A. Berry on August 27, 2008 and is headquartered in Cambridge, MA. The listed name for AXLA is Axcella Health Inc. Common Stock.
CEO
William R. Hinshaw
Employees
64
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
228.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
93.60K
High Today
$6.16
Low Today
$5.65
Open Price
$5.68
Volume
111.45K
52 Week High
$7.73
52 Week Low
$2.25
Collections
Analyst Ratings
89%
of 9 ratings
Buy
89%
Hold
11%
Sell
0%
AXLA Earnings
-$0.95
-$0.63
-$0.32
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 23, Pre-Market